About Arcticdx
Arcticdx: Pioneering Genetic Research for Safer Zinc Supplement Formulations
Arcticdx is a leading biotechnology company that specializes in genetic research and development of innovative solutions for the prevention and treatment of age-related macular degeneration (AMD). The company's groundbreaking research has revealed that zinc supplement formulations, which have been widely used to prevent the progression of AMD, are not safe for 15% of patients. Arcticdx's mission is to develop safer and more effective zinc supplement formulations that can benefit all patients with AMD.
Age-related macular degeneration (AMD) is a common eye disease that affects millions of people worldwide. It is a progressive condition that damages the macula, which is responsible for central vision. As the disease progresses, it can cause severe vision loss or blindness. Zinc supplements have been shown to slow down the progression of AMD in some patients by reducing oxidative stress and inflammation in the retina. However, recent studies have revealed that certain genetic variations can make some patients more susceptible to adverse effects from zinc supplements.
Arcticdx's team of expert scientists has conducted extensive genetic research on AMD patients to identify these genetic variations and their impact on zinc metabolism. The company has developed a proprietary genetic test called "ZincSafe" that can identify these high-risk patients before they start taking zinc supplements. This test enables doctors to personalize their treatment plans based on each patient's unique genetics, ensuring safer and more effective outcomes.
In addition to its groundbreaking research on AMD genetics, Arcticdx also offers innovative solutions for other areas of healthcare such as cancer diagnostics and personalized medicine. The company's cutting-edge technologies enable faster and more accurate diagnosis of cancer through liquid biopsy tests that detect circulating tumor DNA in blood samples.
Arcticdx also offers personalized medicine solutions through its pharmacogenomics testing services. These tests analyze an individual's DNA to determine how they metabolize certain medications, enabling doctors to prescribe drugs with greater precision and avoid adverse drug reactions.
Arcticdx's commitment to innovation and excellence has earned the company numerous accolades and awards. The company's ZincSafe test has been recognized as a breakthrough technology in the field of ophthalmology, and its cancer diagnostics technologies have been hailed as game-changers in the fight against cancer.
In conclusion, Arcticdx is a pioneering biotechnology company that is revolutionizing healthcare through genetic research and innovative solutions. Its groundbreaking research on AMD genetics has revealed important insights into the safety and efficacy of zinc supplements, enabling doctors to personalize their treatment plans for better outcomes. With its cutting-edge technologies for cancer diagnostics and personalized medicine, Arcticdx is poised to make significant contributions to healthcare in the years ahead.